PD-1 Inhibitors Maintenance for cHL Post-autoHCT
PD-1 Inhibitors Maintenance for cHL Post-autoHCT
Recruiting · NCT06812858 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PD-1 Inhibitors Maintenance for cHL Post-autoHCT | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-05-22 | NCT06812858 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| St. Petersburg State Pavlov Medical University | 16 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Medical and Surgical Center named after N.I. Pirogov | Moscow | Russia | 3 |
| National Research Oncology Center | Astana | Kazakhstan | 1 |
| RecruitingP. Hertsen Moscow Oncology Research Institute (MORI) for administrative and economic work - the branch of the FSBI "National Medical Research Radiological Centre" (NMRRC) of the Ministry of Health of the Russian Federation | Moscow | Russia | 1 |
| RM Gorbacheva Research Institute, Pavlov University | Saint Petersburg | Russia | 1 |